MedTrace Logo

Dietary Supplementation With Low-Dose Omega-3 Reduces Salivary TNF-α Levels in Patients With Chronic Periodontitis

NCT02719587 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-03-25

No results posted yet for this study

Summary

The investigators primary objective in this clinical intervention study, therefore, was to explore the impact of omega-3 PUFAs in conjunction with scaling and root planing on salivary markers (in patients with chronic periodontitis.

Conditions

  • Chronic Periodontitis

Interventions

PROCEDURE

Placebo

placebo drug identical except for the fish oil supplement, were only performed at baseline.

PROCEDURE

Omega-3

omega-3 PUFAs supplement, were only performed at baseline.

PROCEDURE

SRP

Instrumentation was performed until the root surface was considered smooth and clean, according to the operator's clinical judgement.

Sponsors & Collaborators

  • İlker KESKINER

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2009-12-31
Completion
2010-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02719587 on ClinicalTrials.gov